Status:
UNKNOWN
Investigation of the Effect of Education on Symptom Management on Symptom Management in Patients With Breast Cancer
Lead Sponsor:
Saglik Bilimleri Universitesi
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
It is used with different treatment options such as chemotherapy, radiotherapy and surgery in the treatment of breast cancer, which is common in women among all cancers in the world. Side effects such...
Eligibility Criteria
Inclusion
- Receiving adjuvant chemotherapy with the diagnosis of breast cancer,
- Receiving CE (cyclophosphamide-epirubicin) or CA (cyclophosphamide-adriamycin) treatment protocol,
- First time receiving chemotherapy,
- Aged between ≥ 18 and ≤ 65,
- Can understand Turkish and can read and write,
- Those whose health status is suitable for participating in the research,
- Having stage I, stage II and stage III breast cancer,
- Identified as patients who volunteered to participate in the study
Exclusion
- Metastasis detected
- Those with a diagnosis of psychiatric disease
- Those who want to leave the research and
- Patients whose general condition deteriorates will not be included in the study.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT05393947
Start Date
July 1 2022
End Date
April 1 2023
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saglik Bilimleri Universitesi
Istanbul, Turkey (Türkiye)